Pricing

Alpine Immune Sciences Inc (ALPN)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Mitchell H. Gold
Employees: 80
Web site: alpineimmunesciences.com
188 EAST BLAINE ST., SUITE 200, SEATTLE, WA, 98102
206-788-4545
Stock Split History
DateRatio
2017-07-25 1:4
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the. treatment of autoimmune and inflammatory diseases.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available